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1. Introduction 
Acrylamide (AC, CH2=CH–CONH2, Chart 1), present in heated foodstuffs [Rice, 2005], has 
been classified by the International Agency for Research on Cancer as ‘‘probably carcinogenic 
to humans” (group 2A) (IARC, 1994). The Scientific Committee on Toxicity, Ecotoxicity and 
the Environment (CSTEE) in the European Union (EU) demonstrated that AC exposure to 
humans should be controlled as low as possible because of its inherently toxic properties 
[Zhang et. al., 2009; Dearfield et. al., 1995]. AC is a low molecular-weight, odorless, and 
colorless compound. It is readily soluble in water and can rapidly polymerize from a monomer 
state to a polymer form [Klaunig, 2008]. AC is biotransformed in vivo to its epoxide 
glycidamide (GDE) by cytochrome P450 2E1 (CYP2E1) [Ghanayem et. al., 2005]. GDE has 
genotoxic properties in both in vitro and in vivo test systems [Kurebayashi & Ohno, 2008]. 
In spite of the possible carcinogenic nature of AC, no consistent effect of AC exposure on 
cancer incidence in humans could be identified [Rice, 2005]. This strikingly contrasts with AC 
subministration in both mice and rats, which may cause tumors at multiple sites [Besaratinia & 
Pfeifer, 2005; 2007]. A plausible hypothesis is this might be caused, at least partially, by the fact 
that AC interacts differently with the mouse and human proteins. AC may interact with 
cysteine residues not engaged in S-S bridges. Indeed, the double bond of conjugated vinyl 
compounds has strong affinity with SH groups [Friedman, 2003; Carere, 2006]. 
 
  
 
 
 
 
 
 
Fig. 1. AC structure. 
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There are six human proteins which are known to bind to AC. For all of them, structural 
information is available. These are five enzymes [Howland et. al., 1980; Sakamoto & 
Hashimoto, 1985] and the serum albumin protein [Ferguson et al., 2010] (Tab. 1). All of them 
are dimers. Inspection of the X-ray structures of all of these targets shows Cys residues may 
be present in the enzymatic active sites and/or solvent exposed (Tab. 1).  
2. Objective 
This work has two main goals. On one hand, using bioinformatics, molecular docking, and 
molecular simulation procedures, we aim at predicting the structural determinants of AC in 
complex with its cellular targets reported in Tab. 1. On the other hand, we aim at detecting 
the difference (if any) of binding these molecules to the correspondent proteins in rodents. 
These differences might contribute to the carcinogenic features of these molecules in rodents 
as opposed to humans.  
 
Protein 
PDB ID of 
human proteins
Sequence 
Identity 
(mouse) 
Cys not engaged in 
disulfur bridges 
Topoisomerase IIα 1ZXM 88% 
Cys216, Cys104, 
Cys392, Cys405, 
Cys170, Cys300 
Creatine Kinase (CK) 3B6R 96% 
Cys74, Cys283*, 
Cys254, Cys141, 
Cys146 
Aldolase 1QO5 95% 
Cys72, Cys239, 
Cys289, Cys338, 
Cys201, Cys149, 
Cys177, Cys134 
Serum albumin 1AO6 72% Cys34 
glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) 
1ZNQ 93% 
Cys152*, Cys156, 
Cys247 
Enolase 2PSN 97% 
Cys118, Cys356, 
Cys336, Cys338, 
Cys398, Cys388 
Table 1. Structural information of AC targets. For human proteins, for which the 
experimental structures are available, the PDB codes are included. For mouse proteins, as 
there is no structure available, the sequence identities with human proteins are reported. 
The cysteines present in the active sites of the enzymes are shown with an asterisk while the 
solvent-exposed ones are highlighted in bold. 
3. Methodology 
3.1.  Molecular docking 
Docking methods attempt to find the “best” matching between two molecules, typically a 
receptor and a ligand [Halperin et. al., 2002]. Hence, they make the prediction of ligand 
conformation and orientation within a targeted binding site [Kitchen et. al., 2004; Halperin 
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et. al., 2002]. This prediction is carried out by performing a conformational space search 
based on an ad hoc potential energy function. [Halperin et. al., 2002].  
The accuracy of the method can be investigated by docking ligands into the protein from 
which they were extracted (self-docking) and by docking them into its target protein in a 
different conformation (usually taken from different protein/ligand complexes) (cross-
docking)  [Kawatkar et. al., 2009; Sutherland et. al., 2007]. 
The increasing availability of protein three-dimensional structures combined with 
continuing computational advances have made docking a very important tool for small-
molecule lead discovery [Campbell et. al., 2003]. 
Here we use the Genetic Optimisation for Ligand Docking (GOLD) program [Jones et. al., 
1995; 1997].  GOLD is an automated ligand docking program that uses a genetic algorithm to 
explore the full range of ligand's conformational flexibility with partial flexibility of the 
protein. It satisfies the fundamental requirement that the ligand must displace loosely 
bound water on binding [Jones et. al., 1995; 1997].  
GOLD uses a genetic algorithm (GA) to optimize a variety of structural parameters: (a) 
dihedrals of ligand's rotatable bonds; (b) ligand's ring geometries; (c) dihedrals of protein 
OH groups and NH3+ groups; and (d) the position of the ligand in the binding site [Verdonk 
et. at., 2003]. 
In GOLD, one minimizes a molecular mechanics–like function with four terms, the so called  
GOLD Fitness (Eq. 1) [Jones et al., 1995; 1997]: 
 
GOLD Fitness  =  Shb_ext +  Svdw_ext  +  Shb_int  + Svdw_int (1) 
 
Shb_ext  decreases with the number of protein–ligand hydrogen-bonds;  Svdw_ext  decreases with 
the van der Waals interactions; Shb_int decreases with the intramolecular hydrogen bonds in 
the ligand; Svdw_int  increases with the intramolecular strain in the ligand [Verdonk et. al., 
2003]. The scoring function is taken as the negative of the GOLD Fitness [Jones, 1995; 1997]. 
The larger the scoring function of a pose, the higher its rank. 
We have performed GOLD-based docking for the human proteins in Tab. 1. These are: 
human topoisomerase IIα [Sciandrello et al, 2010]; human-brain creatine kinase [Lü Z-R. et 
al, 2009]; human aldolase [Dobryszycki et al., 1999a; 1999b]; human serum albumin 
[Ferguson et al., 2010]; human glyceraldehyde-3-phosphate dehydrogenase [Sakamoto & 
Hashimoto, 1985] and human enolase [Howland et. al., 1980]. Since alkylation by acrylamide 
is limited to cysteine SH groups, the best cys residues putatively binding AC will be those 
ones with the shortest distances between S atom and AC.  
For rodents, there is no experimental structure available. Fortunately, the sequence identity 
(SI) between the mouse proteins and the human enzymes is always greater than 88%, except 
for serum albumin, for which SI= 72% (Tab. 1 and Fig. S1, SI). The structure of the latter was 
built by homology modeling using the server HHpred [Soding, 2005; Soding et. al., 2005; 
Hildebrand et. al., 2009].  
The active site was defined here as a sphere with radius of 10 Å centered at the sulfur atoms 
of the Cys residues of Tab. 1. The cavity detection algorithm, LIGSITE [Hendlich et. al., 
1997], was used to restrict the region of interest to concave, solvent-accessible surfaces. To be 
sure that most of the high-affinity binding modes were explored, the genetic algorithm was 
run 200 times for each complex examined.  
The poses were ranked using the GOLD Fitness [Jones et al., 1995; 1997] as well as in terms 
of the number of contacts between AC and the target cysteine residues. 
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4. Results and discussion  
Here we report the results for AC docking to all its known human targets [Friedman, 2003]. 
We also discuss the putative binding of AC to the correspondent mouse proteins, for which 
binding has not been shown. We consider here Cys residues not involved in S-S bridges 
(Target cysteines hereafter, see Tab. 1).  
Table 2 shows the docking score values for the best AC poses in all targets, the values are in 
Kcal/mol. It can be seen that the best score obtained was for creatine kinase, -46.2, this result 
shows the great protein-ligand interaction provided by the docking calculations, this result 
is in good agreement with experiments, which have shown that CK is alkylated by AC. 
 
Protein Docking score 
Topoisomerase IIα -23.3 
Creatine Kinase (CK) -46.2 
Aldolase -21.3 
Serum albumin -22.6 
glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) 
-28.1 
Enolase -28.3 
Table 2. Docking score values. The lower the score, the better the binding. 
In the topoisomerase enzyme (Fig. 2), the cysteine(s) that react with AC were not identified 
experimentally. The X-ray structure [Wei et. al., 2005] features six target cysteines in each 
subunit, four of which are solvent-exposed (Tab. 1). Our docking procedure suggests that, in 
the most likely pose, AC interacts with Cys 405 (Fig. 3). In all figures, distances are reported 
in Angstroms. 
 
 
Fig. 2. 3D structure of topoisomerase enzyme [Sciandrello et al, 2010]. The four exposed 
cysteines (Cys104, Cys216, Cys392 and Cys405) are named and indicated in licorice 
representation. 
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Fig. 3. AC interactions with Lys287, Met303 and Cys405 residues inside topoisomerase 
enzyme. 
The SI between human and mouse proteins is as high as 88% (Fig. S2, SI). In particular, all of 
the residues surrounding the target cysteines are conserved. Inspection of the structure and 
of the sequence alignment in Fig. S2 strongly suggests that the chemical environment of the 
target cysteines in the mouse proteins is basically the same as in the human ones. The same 
argument applies to all of the enzymes considered here. Hence, AC might bind to mouse 
topoisomerase in a similar way as it does to the human protein. 
The human enzyme creatine kinase (Fig. 4) has five target cysteines in each subunit (Tab. 1). 
One of them (Cys283) is located in each of the active sites (Fig. 5) and it is known 
experimentally to bind to AC [Matsuoka et. al., 1996; Meng et. al., 2001]. Consistently with 
experiment, we find that in the best pose AC interacts with Cys283 (Fig. 5). AC is not found 
to bind to any other target cysteine. 
The SI between human and mouse proteins is considerably high (96%) and hence also in this 
case AC might bind to the mouse creatine kinase in a similar fashion. 
The human enzyme enolase (Fig. 6) has 6 target cysteines in each binding site. Our docking 
procedure suggests that Cys 388 may bind to AC (Fig. 7). Because of the large SI between 
human and mouse protein (97%), AC might bind to the correspondent Cys residue (Cys 388, 
see Fig. S3, SI) also in the mouse protein. 
The human enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (Fig. 8) has 
three target cysteines in each dimer. One of them is present in each active sites, Cys152 (Fig. 
9). Experiments show that Cys152 in fact interacts with AC [Campian et. Al., 2002]. Our 
docking is consistent with the experimental evidence (Fig. 9). 
The protein human aldolase (Fig. 10) have eight and one target cysteine (Cys239, about 100 
times more reactive than remaining exposed groups) in each subunit. Human serum 
albumin (Fig. 11) has 35 cysteine residues with 17 disulphide bonds. Sulphydryl residue in 
position 34 is left free to react with thiols of the environment [Candiano et al., 2009]. Our 
docking procedure could identify binding poses for AC in neither proteins. This suggests 
that conformational rearrangements, which are not taken into account in the docking 
procedure, might allow AC to bind to one or more Cys residues. For mouse aldolase,  the  SI  
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Fig. 4. 3D structure of creatine kinase enzyme [Lü Z-R. et al, 2009]. The Cys283, which is 
located in the active side is named and indicated in licorice representation. 
 
 
 
 
Fig. 5. AC interactions with Leu201, Thr59 and Cys283 residues inside creatine kinase active 
site. 
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Fig. 6. 3D structure of enolase enzyme [Howland et. al., 1980]. The Cys388, which binds AC 
is named and indicated in licorice representation. 
 
 
 
Fig. 7. AC interactions with Val142, Lys421, Ser140 and Cys388 residues, inside enolase 
enzyme. 
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Fig. 8. 3D structure of GAPDH enzyme [Sakamoto & Hashimoto, 1985]. The Cys152, which 
binds AC is named and indicated in licorice representation. 
 
 
 
Fig. 9. AC interactions with Gly212, Thr211, Ser151 and Cys152 residues inside GAPDH 
active site. 
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is as high as 95%. This suggests similar consideration for this species. Instead, for mouse 
serum albumin, SI = 72% (see Fig. S1, SI). In the structure of the mouse serum albumin, 
which was built by homology modeling, there are two target cysteines (at position 58 and 
603). Therefore, we may expect rather different binding in the two species. Because of the 
limitations of the docking procedure with homology models, we did not proceed to 
investigate AC binding poses to this protein [Leach, 2001; McGovern & Shoichet, 2003].  
 
 
Fig. 10. 3D structure of aldolase enzyme [Dobryszycki et al., 1999a; 1999b]. All the cysteine 
residues are in licorice representation with indication of the most reactive one, Cys239. 
 
 
Fig. 11. 3D structure of serum albumin [Ferguson et al., 2010]. The only cysteine free to react, 
Cys34 is indicated in licorice representation. 
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5. Conclusions 
By means of molecular docking methodology, we have studied the interactions between AC 
and its human targets. The investigation is complemented by a study of AC interactions 
with the mouse protein, for which binding has not been reported so far. The calculations are 
consistent with the available biochemical data and they provide novel information on 
putative cysteines to which AC could be bound in both mouse and human protein. In the 
case of one protein, serum albumin, binding is likely to occur at different locations in the 
protein. Hence, this difference could contribute to the experimentally known differences in 
toxic properties of AC in humans and mice. 
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